Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-020-09367-9
Abstract: Pancreatic cancer is one of the most aggressive gastrointestinal malignancies despite multimodality therapy. In the last several years, genomic studies have revealed that carcinogenesis is driven largely by key driver mutations that can be targeted… read more here.
Keywords: immunotherapy targeted; therapy; landmark series; pancreatic cancer ... See more keywords